Exhibit 10.26
ADDENDUM No. 1
to the
PATENT AND KNOW-HOW LICENSE
AGREEMENT
between
PIERRE FABRE MEDICAMENT
S.A.
and
NOVACEA, Inc.
Dated
February 21,
2006
ADDENDUM No. 1
This ADDENDUM No. 1 to the Patent and
Know-How License Agreement effective as of February 21, 2006
(the “ADDENDUM No. 1 Effective Date”) is executed by
and between P IERRE
F ABRE M EDICAMENT S.A., a corporation organized under the laws of
France with headquarters at 45, place Abel-Gance, 92100 B
OULOGNE , F RANCE (“P IERRE F ABRE ”), and, N OVACEA ,
I NC ., a Delaware corporation with a principal place
of business at 601 Gateway Boulevard, Suite 800, S
OUTH S AN
F RANCISCO ,
C ALIFORNIA
94080, U.S.A. (“N
OVACEA ”).
RECITALS
WHEREAS,
the Parties have entered into a
Patent and Know-How Agreement effective as of July 19, 2005
(the “Agreement”).
WHEREAS, the Parties have agreed to correct Sections
18.1.1 and 18.1.2 of the Agreement and replace them with the
language in Article 1 hereof.
NOW, THEREFORE, in consideration of the premises
and the mutual covenants and agreements herein contained, the
Parties agree as follows:
ARTICLE 1– MODIFICATION OF SECTION
18.1.1
Section 18.1.1 of the Agreement
is deleted and replaced by the following language:
“Section 18.1.1.
Continuing License for NOVACEA. N OVACEA shall have a non-exclusive, worldwide,
perpetual,
